Open Access Biomedical Publisher Using Post Publication Peer Review
Professor of Surgery and Nuclear Medicine Florida International University College of Medicine
11200 SW 8th Street, HLS II 693 Miami, Florida 33199 United States of America 33160
Seza Gulec, MD, FACSProfessor of Surgery, Nuclear Medicine/ Radiology & Biomedical Engineering
Chief of Surgical Oncology
Director of Surgical and Nuclear Oncology Research
Florida International University Herbert Wertheim College of Medicine
Seza Gulec, MD, FACS is a professor of surgery, Nuclear Medicine/Radiology, and Biomedical Engineering. He is one of the founding faculty members at the FIU College of Medicine. Dr. Gulec received his medical degree at Ankara University College of Medicine, Ankara, Turkey. He trained in surgery in Louisiana State University Health Sciences Center in New Orleans, LA, in nuclear medicine and nuclear oncology at the Memorial Sloan-Kettering Cancer Center in New York, NY, and in surgical oncology at the John Wayne Cancer Institute in Santa Monica, CA.
Dr. Gulec is the Chief of Surgical Oncology, and Director of Research at the College of Medicine's Department of Surgery. His areas of clinical expertise include treatment of thyroid and parathyroid diseases, carcinoid and neuroendocrine tumors, melanoma, breast cancer, primary and metastatic liver cancers, and pancreatic cancer. Dr. Gulec has started a comprehensive cancer program at the FIU/JNMC, integrating surgical and nuclear oncology. This unique model involves PET/CT-guided surgical treatment planning and radionuclide therapy of advanced cancers.
Dr. Gulec is an established researcher in the fields of surgical and nuclear oncology. He has authored landmark publications in lymphatic mapping, sentinel node biopsy, radioguided surgery, radionuclide therapy, and molecular imaging. The main focus of Dr. Gulec's current research is molecular imaging and targeted radionuclide therapy in solid tumors. His laboratory is actively involved in the development of novel PET imaging agents, and radioimmuno, radiopeptide, and radiomicrosphere therapy strategies.
I support WebmedCentral, the portal promoting post publication peer review in an open and transparent manner
All site content, except where otherwise noted, is licensed under a
Creative Commons Attribution License